.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
Federal Trade Commission
Colorcon
Dow
Chubb
Chinese Patent Office
Fuji
Cipla
AstraZeneca

Generated: September 26, 2017

DrugPatentWatch Database Preview

Triflupromazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for triflupromazine hydrochloride and what is the scope of triflupromazine hydrochloride freedom to operate?

Triflupromazine hydrochloride
is the generic ingredient in one branded drug marketed by Bristol Myers Squibb and Apothecon, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for triflupromazine hydrochloride.

Summary for Generic Name: triflupromazine hydrochloride

Tradenames:1
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list2
Bulk Api Vendors: see list27
Clinical Trials: see list2,276
Patent Applications: see list187
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:triflupromazine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon
VESPRIN
triflupromazine hydrochloride
INJECTABLE;INJECTION011325-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
VESPRIN
triflupromazine hydrochloride
INJECTABLE;INJECTION011325-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
VESPRIN
triflupromazine hydrochloride
TABLET;ORAL011123-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
VESPRIN
triflupromazine hydrochloride
TABLET;ORAL011123-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
VESPRIN
triflupromazine hydrochloride
TABLET;ORAL011123-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Apothecon
VESPRIN
triflupromazine hydrochloride
INJECTABLE;INJECTION011325-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
US Department of Justice
Mallinckrodt
AstraZeneca
Teva
Fuji
Covington
UBS
Fish and Richardson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot